Related Party Transactions - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Mar. 28, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Research and development related expense related party	$ 0	$ 1,500,000
Accrued research and development-related expenses- related party					$ 500,000
Common stock, shares issued	29,741,445		19,402,658
Adjuvant Global Health Agreement | Initial Public Offering
Related Party Transaction [Line Items]
Common stock, shares issued				166,666
Total additional investment				$ 2,500,000